Drug Profile
Research programme: cyclo-oxygenase inhibitors - Sulfidris
Alternative Names: ACS 18; ACS 27Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Sulfidris
- Class
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Colorectal-cancer(Prevention) in Italy
- 17 Aug 2007 Preclinical trials in Colorectal cancer prevention in Italy (unspecified route)